Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
REATA PHARMACEUTICALS INC (RETA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
SC 13D/A
| BIOGEN INC. reports a 0% stake in REATA PHARMACEUTICALS, INC. |
| 09/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/26/2023 |
SC 13D/A
| ROSE WILLIAM reports a 0% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 08/24/2023 |
SC 13D/A
| ROSE WILLIAM reports a 9.1% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 08/01/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/31/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/09/2020 |
SC 13D/A
| ROSE WILLIAM reports a 9.7% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 11/20/2019 |
SC 13D/A
| ROSE WILLIAM reports a 10.8% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 11/14/2018 |
SC 13D/A
| ROSE WILLIAM reports a 12.2% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 07/31/2018 |
SC 13D/A
| CPMG Inc reports a 19.5% stake in Reata Pharmaceuticals, Inc. |
| 07/31/2018 |
SC 13D/A
| Huff James Warren reports a 4.5% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 07/31/2018 |
SC 13D/A
| ROSE WILLIAM reports a 12.4% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 12/29/2017 |
SC 13D/A
| CPMG Inc reports a 22.9% stake in Reata Pharmaceuticals, Inc. |
| 12/08/2017 |
SC 13D/A
| ROSE WILLIAM reports a 13.6% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 11/13/2017 |
SC 13D/A
| Novo A/S reports a 0% stake in Reata Pharmaceuticals, Inc. |
| 11/13/2017 |
SC 13D/A
| CPMG Inc reports a 21.8% stake in Reata Pharmaceuticals, Inc. |
| 08/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/01/2017 |
SC 13D/A
| ROSE WILLIAM reports a 15.4% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 08/01/2017 |
SC 13D/A
| Huff James Warren reports a 5.1% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 07/12/2017 |
SC 13D/A
| ROSE WILLIAM reports a 18.9% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 06/26/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 06/23/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 06/15/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 03/06/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 03/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 03/03/2017 |
SC 13D/A
| ROSE WILLIAM reports a 19.9% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 03/03/2017 |
SC 13D/A
| Huff James Warren reports a 6.5% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 01/04/2017 |
SC 13D/A
| REATA PHARMACEUTICALS INC reports a 33.7% stake in Reata Pharmaceuticals, Inc. |
| 01/03/2017 |
SC 13D/A
| ROSE WILLIAM reports a 28.7% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 12/20/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 12/09/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 12/07/2016 |
SC 13D/A
| ROSE WILLIAM reports a 30.6% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 12/07/2016 |
SC 13D/A
| Huff James Warren reports a 9.6% stake in § 240. REATA PHARMACEUTICALS, INC. |
|
|
|